Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Paricio M, Lorites J, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Lima J, Grifols C, Torres M, Costa M, Bozzo J, Szczepiorkowski ZM, Hendrix S, Páez A. Boada M, et al. Among authors: anaya f. Alzheimers Dement. 2020 Oct;16(10):1412-1425. doi: 10.1002/alz.12137. Epub 2020 Jul 27. Alzheimers Dement. 2020. PMID: 32715623 Free PMC article. Clinical Trial.
Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.
Boada M, Anaya F, Ortiz P, Olazarán J, Shua-Haim JR, Obisesan TO, Hernández I, Muñoz J, Buendia M, Alegret M, Lafuente A, Tárraga L, Núñez L, Torres M, Grifols JR, Ferrer I, Lopez OL, Páez A. Boada M, et al. Among authors: anaya f. J Alzheimers Dis. 2017;56(1):129-143. doi: 10.3233/JAD-160565. J Alzheimers Dis. 2017. PMID: 27911295 Free PMC article. Clinical Trial.
Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Puente O, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Alegret M, Grifols C, Barceló M, Bozzo J, Szczepiorkowski ZM, Páez A; AMBAR Trial Group. Boada M, et al. Among authors: anaya f. Alzheimers Dement. 2022 Jul;18(7):1314-1324. doi: 10.1002/alz.12477. Epub 2021 Nov 2. Alzheimers Dement. 2022. PMID: 34726348 Free PMC article. Clinical Trial.
Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization.
Boada M, Ortiz P, Anaya F, Hernández I, Muñoz J, Núñez L, Olazarán J, Roca I, Cuberas G, Tárraga L, Buendia M, Pla RP, Ferrer I, Páez A. Boada M, et al. Among authors: anaya f. Drug News Perspect. 2009 Jul-Aug;22(6):325-39. doi: 10.1358/dnp.2009.22.6.1395256. Drug News Perspect. 2009. PMID: 19771322 Free article. Review.
Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response.
Palacios-Mendoza MA, Martínez Ginés ML, Melgarejo Otálora PJ, Cuello JP, Sánchez-Soblechero A, Lozano Ros A, Aparcero-Suero JA, López Anguita S, Anaya F, García Domínguez JM. Palacios-Mendoza MA, et al. Among authors: anaya f. Neurol Sci. 2020 Sep;41(9):2569-2574. doi: 10.1007/s10072-020-04382-w. Epub 2020 Apr 4. Neurol Sci. 2020. PMID: 32248320
Plasma exchange as an effective salvage therapy in AZD1222 vaccine-induced thrombotic thrombocytopenia: a case report.
de Miguel-Sanchez CJ, Arguello-Tomas M, Perez-Rus G, Vazquez-Allen P, Mijaylova-Antonova AG, Anaya F, Lopez-Esteban M, Diez-Martin JL, Gil-Nuñez AC, Pascual-Izquierdo C. de Miguel-Sanchez CJ, et al. Among authors: anaya f. Blood Transfus. 2022 Mar;20(2):152-155. doi: 10.2450/2021.0220-21. Epub 2021 Dec 2. Blood Transfus. 2022. PMID: 34967727 Free PMC article. No abstract available.
107 results